FDA Warning Letter — Novo Nordisk Inc.
The FDA took a Warning Letter action against Novo Nordisk Inc. on March 5, 2026 (Plainsboro, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Novo Nordisk Inc.
- Date
- March 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Plainsboro, NJ (United States)